Médecine traditionnelle et naturopathie clinique

Abstrait

Chinese Drug can be Used in Combination with Monoclonal Antibody Medicines to Reduce the Side Effects of COVID- 19

Robert Wallace

The mortality rate of the recent global epidemic corona virus disease 2019(COVID- 19) is presently as high as 7%.The SARS- CoV- 2 contagion is the malefactor behind COVID- 19. SARS- CoV- 2 is an enveloped single- stranded RNA contagion; the genome encodes four types of the structural proteins S protein, E protein (envelope protein),M protein (matrix protein) and N protein (nucleocapsid protein). In COVID- 19, monoclonal antibodies have played a significant part in opinion and treatment. This composition compactly introduced the development of monoclonal antibodies targeting on S protein and N protein, which represents the main direction of monoclonal antibody medicines used in the opinion and treatment of COVID- 19. Meanwhile, the traditional Chinese drug also plays important part in the fight against COVID- 19 by regulating human immunity. The composition introduced the use of traditional Chinese drug in fighting against COVID- 19.